Cell therapy in Parkinson's disease–stop or go?
SB Dunnett, A Björklund, O Lindvall - Nature Reviews Neuroscience, 2001 - nature.com
SB Dunnett, A Björklund, O Lindvall
Nature Reviews Neuroscience, 2001•nature.comThe results of the first double-blind placebo-controlled trial using grafts of embryonic tissue
to treat Parkinson's disease have aroused widespread interest and debate about the future
of cell replacement therapies. What are the key issues that need to be resolved and the
directions in which this technology is likely to develop?
to treat Parkinson's disease have aroused widespread interest and debate about the future
of cell replacement therapies. What are the key issues that need to be resolved and the
directions in which this technology is likely to develop?
Abstract
The results of the first double-blind placebo-controlled trial using grafts of embryonic tissue to treat Parkinson's disease have aroused widespread interest and debate about the future of cell replacement therapies. What are the key issues that need to be resolved and the directions in which this technology is likely to develop?
nature.com